Results

Total Results: 3,707 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

  1. psnet.ahrq.gov/web-mm/toxic-tachycardia
    March 01, 2005 - Therapy for her hyperthyroidism was initiated, and she was discharged without complications. … Both thyroid storm and myxedema coma have high mortality rates even with therapy.( 3 ) Although atrial … in addition to treatment of thyrotoxic storm are essential. … Amiodarone-induced thyrotoxicosis typically presents months after starting therapy. … Surgeon September 25, 2019 WebM&M Cases Correct Treatment
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
    January 01, 2007 - Analytic framework for evaluating the effectiveness and safety of treatments for renal artery stenosis … Stents were used only rarely and medical therapies varied both between and within studies. … were prospective, followed the natural history of 721 patients who mostly received various medical therapies … Including a third RCT with a substantial treatment crossover (medical therapy to angioplasty) at 3 months … , US Department of Health and Human Services/National Institutes of Health/National Institute of Diabetes
  3. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/33768/psn-pdf
    June 01, 2014 - I certainly couldn't have conducted the treatment, and on and on. … To do that, you need to understand all the events that happen during a case, all the resources, treatments … Think about it—a hundred years ago, to get their numbers checked, a person with diabetes had to go to
  4. www.uspreventiveservicestaskforce.org/uspstf/document/cost-effectiveness-analyses-of-population-based-screening-for-abdominal-aortic-aneurysm-evidence-synthesis/abdominal-aortic-aneurysm-screening-february-2005
    February 15, 2005 - How will differences in treatment effectiveness affect cost-effectiveness estimates for AAA screening … and quality-of-life estimates were included for renal failure, stroke, major amputation (related to diabetes … Downstream costs post-treatment were included. … How will differences in treatment effectiveness affect cost-effectiveness estimates for AAA screening … None considered patient-incurred burdens of time and money related to AAA screening and treatment.
  5. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2007_MaskedStats_Core_Weighted.PDF
    January 01, 2007 - PROC W/O CC 1360 0.00 294: DIABETES AGE >35 242107 0.61 295: DIABETES AGE 0-35 98752 0.25 296: NUTRITIONAL … 0.53 47: Other and unspecified benign neoplasm 165472 0.42 48: Thyroid disorders 46283 0.12 49: Diabetes … mellitus without complication 22898 0.06 50: Diabetes mellitus with complications 510523 1.29 51: … 56370 0.14 146: Treatment; fracture or dislocation of hip and femur 269531 0.68 147: Treatment; fracture … radiology for cancer treatment 50629 0.13 212: Diagnostic physical therapy 16344 0.04 213: Physical
  6. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2008_MaskedStats_Core_Weighted.PDF
    January 01, 2008 - PROC W/O CC 1,675 0.00% 294: DIABETES AGE >35 248,762 0.62% 295: DIABETES AGE 0-35 97,764 0.25% 296 … W/O CC 29,539 0.07% 523: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O CC 192,188 … mellitus without complication 20,794 0.05% 50: Diabetes mellitus with complications 519,522 1.30% … ulna 54,711 0.14% 146: Treatment; fracture or dislocation of hip and femur 271,839 0.68% 147: Treatment … radiology for cancer treatment 46,315 0.12% 212: Diagnostic physical therapy 13,852 0.03% 213: Physical
  7. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Core_Weighted.PDF
    January 01, 2012 - PROC W/O CC 1,735 0.00% 294: DIABETES AGE >35 239,240 0.66% 295: DIABETES AGE 0-35 114,470 0.31% 296 … W/O CC 21,365 0.06% 523: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O CC 166,990 … mellitus without complication 19,180 0.05% 50: Diabetes mellitus with complications 528,030 1.45% … ulna 45,410 0.12% 146: Treatment; fracture or dislocation of hip and femur 245,390 0.67% 147: Treatment … radiology for cancer treatment 35,340 0.10% 212: Diagnostic physical therapy 9,270 0.03% 213: Physical
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/protocol-pharm-pregnant-women_0.pdf
    December 05, 2018 - Maternal and Fetal Effects of Mental Health Treatments in Pregnant and Breastfeeding Women: A Systematic … Practice Center Systematic Review Protocol Project Title: Maternal and Fetal Effects of Mental Health Treatments … consequences of perinatal psychiatric disorders, information about the efficacy and side effects of treatments … pharmacotherapy, and psychotherapy KQ 1, KQ 3: Active comparators, no comparators KQ 2, KQ 4: • Treatments … /preterm birth, preeclampsia, gestational hypertensive disorders, glucose intolerance/gestational diabetes
  9. integrationacademy.ahrq.gov/sites/default/files/2020-06/Lexicon_ExecSummary.pdf
    January 01, 2020 - With systematic follow-up and adjustment of treatment plans if patients are not improving as expected … With the unified care plan, treatment, referral activity, and manner of support to patient and family … With systematic follow-up and adjustment of treatment plans if patients are not improving as expected … identification with registry and tracking/coordinating functions Complex or specialized mental health therapies … other Medical conditions Patients with one or more medical diseases or conditions, e.g., diabetes
  10. hcup-us.ahrq.gov/reports/statbriefs/sb212-MRSA-Hospital-Stays-California-2013.jsp
    October 01, 2016 - of the hospitalization are then compared with those who acquired the infection following receipt of treatment … accounted for 3.5 percent of other MRSA hospital stays, and fluid and electrolyte disorders, anemia, and diabetes … endocrine, and metabolic disorders 55 Fluid and electrolyte disorders 59 Anemia 50 Diabetes … However, if a patient received long-term care, rehabilitation, or treatment for a psychiatric or chemical … also include various types of outpatient services such as observation stays, lithotripsy, radiation therapy
  11. www.ahrq.gov/sites/default/files/2024-04/ratliff-report.pdf
    January 01, 2024 - factors contribute to operative outcomes may significantly improve patient engagement in discussion of treatment … 24.3 Hypertension 115,230 33.5 496,143 65.2 Cardiac disorder other than hypertension 324 <1 4,525 <1 Diabetes … 33.4 Cardiac disorder other than hypertension 121 <1 Cardiac disorder other than hypertension 213 <1 Diabetes … mellitus 14,312 11.6 Diabetes mellitus 25,443 11.3 Cancer 5,487 4.4 Cancer 12,353 5.5 Gastroesophageal … mellitus 45,207 24.4 Diabetes mellitus 139,112 23.7 Cancer 20,103 10.9 Cancer 72,621 12.4 Gastroesophageal
  12. psnet.ahrq.gov/perspective/role-community-pharmacists-patient-safety
    October 24, 2021 - formulations, 1 and specialty pharmacies where patients receive outpatient care for complex medication therapies … process, the community pharmacist provides a clinical review of prescribed medications to ensure the therapies … immunizations, opioid management, smoking cessation efforts, and management of chronic diseases such as diabetes … So there’s a whole therapeutic profile review that occurs in every medication that's dispensed in the … This means that the time the pharmacist spends conducting the therapeutic review, clarifying questions
  13. www.ahrq.gov/research/findings/final-reports/iomracereport/reldata2.html
    May 01, 2018 - While Unequal Treatment recommends the Office of Management and Budget (OMB) race and ethnicity categories … Since the release of Unequal Treatment , evidence of disparities in health and health care among racial … under study; the number or proportion of those ethnicities that might have a specific condition such as diabetes … Health care comprises the prevention, treatment, and rehabilitation interventions that are provided to … Disparities in health care (e.g., in access, in the rate at which a treatment is provided when indicated
  14. digital.ahrq.gov/sites/default/files/docs/publication/r18hs017308-samore-final-report-2011.pdf
    January 01, 2011 - 1.18,3.68 Chronic obstructive pulmonary disease 1.15 0.40,3.27 Congestive heart failure 1.06 0.48,2.35 Diabetes … Shared decision making between patients and physicians is considered optimal for determining treatments … Shared decision making results in appropriate treatments for patient needs -determined by patient disclosure … Treatments resulting from shared decision making can be incorporated successfully into patient’s lives … In addition, patients reported their preference for how decisions regarding treatments are made.
  15. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/33680/psn-pdf
    March 22, 2009 - San Francisco, Director of the UCSF Center for Vulnerable Populations, and Chief of the California Diabetes … method is simply asking patients to report, in their own words, what they're going to do with their diabetes … the procedure they just agreed to involved; or what the risks, benefits, tradeoffs, and alternative treatments
  16. psnet.ahrq.gov/perspective/artificial-intelligence-and-patient-safety-promise-and-challenges
    March 27, 2024 - options or caution against potential treatment-related complications, thus reducing diagnostic errors … If the patient does develop sepsis eight or 12 hours later, and then we start treatment, then the AI … I’m going to initiate treatment right away.” … types of patients entering into the system, but drift can also result from changes to diagnostics, treatments … There are pharmacy and therapeutics committees at hospitals continually looking at this information,
  17. psnet.ahrq.gov/perspective/conversation-withpatrick-tighe-about-artificial-intelligence
    March 27, 2024 - If the patient does develop sepsis eight or 12 hours later, and then we start treatment, then the AI … I’m going to initiate treatment right away.” … types of patients entering into the system, but drift can also result from changes to diagnostics, treatments … There are pharmacy and therapeutics committees at hospitals continually looking at this information, … options or caution against potential treatment-related complications, thus reducing diagnostic errors
  18. cds.ahrq.gov/sites/default/files/cds/artifact/18/Enhanced%20CDS%20Artifact%20Based%20on%20Pilot%20Implementation_Final.docx
    October 01, 2017 - CMS347: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease demonstrated data element … for the Prevention and Treatment of Cardiovascular Disease … Conditions Published guidelines and rules are often written using non-coded generic Condition terms such as “diabetes … · Demographics: Guidelines, particularly for invasive procedures and long-term therapies, may have … to have different time thresholds for recommending thrombolysis, based on their experience and other therapeutic
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_white-paper.pdf
    September 01, 2013 - contributed clinical data to provide information on “real world” practice and the effectiveness of treatments … registries currently exist for a wide range of chronic or rare conditions, including many forms of cancer, diabetes … recruit patients for clinical trials to learn about a particular disease or condition; to develop therapeutics … PPRs have also added to disease and treatment knowledge. … • Research across conditions/concomitant treatments.
  20. www.ahrq.gov/sites/default/files/2024-03/kennerly-report.pdf
    January 01, 2024 - trigger, the presence of an AE, the harm score of an AE, the preventability of an AE, attribution, treatment … for the adverse event, and the outcome of the treatment for each scenario. … Diabetes? 7(41.2) 5(14.7) 0.04** b. Chronic or long-term liver condition? 1(5.9) 1(2.9) 0.61** c. … AE-positive patients were at a significantly higher likelihood of having diabetes, asthma, or COPD and … The effectiveness of implementing an electronic health record on diabetes care and outcomes.